The effects of coronary injections of iodixanol, iopamidol, and ioxaglate on contractility and electrophysiology.
Morris
T W
TW
University of Rochester Medical Center, NY 14642.
Dukovic
D
D
Pagani
E
E
D000818:Animals; D003287:Contrast Media / Q000008:administration & dosage / Q000633:toxicity; D003331:Coronary Vessels; D003974:Diatrizoate Meglumine / Q000008:administration & dosage / Q000633:toxicity; D004285:Dogs; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D007269:Injections, Intra-Arterial; D007479:Iopamidol / Q000008:administration & dosage / Q000633:toxicity*; D007485:Ioxaglic Acid / Q000008:administration & dosage / Q000633:toxicity*; D009200:Myocardial Contraction / Q000187:drug effects*; D017180:Tachycardia, Ventricular / Q000139:chemically induced; D014283:Triiodobenzoic Acids / Q000008:administration & dosage / Q000633:toxicity*; D014693:Ventricular Fibrillation / Q000139:chemically induced
D003287:Contrast Media; D014283:Triiodobenzoic Acids; D003974:Diatrizoate Meglumine; C044834:iodixanol; D007479:Iopamidol; D007485:Ioxaglic Acid